Tilray Brands Inc vs Vanguard Total International Stock Index Fund ETF — how do they compare? Tilray Brands Inc trades at $4.21 (market cap $577.15M), while Vanguard Total International Stock Index Fund ETF trades at $87.65. The key difference: Vanguard Total International Stock Index Fund ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| TLRY | VXUS | |
|---|---|---|
Market Cap | $577.15M | — |
Sector | Health | Sector/Thematic |
52-Week High | $21.00 | $88.41 |
52-Week Low | $3.88 | $72.17 |
Enterprise Value | $744.29M | — |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $4.30, down 4.44% with a bearish technical outlook. The company reported record fiscal 2026 revenue of $915M but continues to post significant losses with a -13.27% net margin. Recent news highlights expansion in spirits distribution and medical cannabis production, though regulatory uncertainty weighs on sentiment. The stock trades below book value with a P/S of 0.51 and P/B of 0.36, suggesting potential undervaluation despite profitability challenges.
TLRY presents a high-risk opportunity with mixed signals. The discounted valuation and expanding beverage/alcohol business offer upside potential, but persistent losses, negative cash flow, and cannabis regulatory delays create substantial headwinds. Analyst consensus leans cautious with 65% hold ratings, reflecting the stock's speculative nature amid ongoing operational challenges.
VXUS trades at $88.08, down 0.37% with a bullish technical signal from moving averages. The ETF offers broad international diversification across developed and emerging markets at a low expense ratio of 0.06%. Recent institutional buying by firms like 1607 Capital Partners and Bessemer Group indicates confidence in international stock prospects. Technical analysis shows support at $87-$88 and resistance at $88-$89 levels.
International diversification at discounted valuations compared to U.S. markets presents a compelling opportunity, though currency risks and foreign tax implications for dividend investors remain key considerations. The ETF's low-cost structure and broad exposure position it well for potential long-term outperformance as global markets may be entering a period of relative strength.
Trailing returns across standard periods
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →